These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 10718325

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Recovery of hearing following cisplatin ototoxicity in the guinea pig.
    O'Leary SJ, Klis SF.
    Anticancer Res; 2002; 22(3):1525-8. PubMed ID: 12168832
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Cisplatin ototoxicity. An electrophysiological dose-effect study in albino guinea pigs.
    Stengs CH, Klis SF, Huizing EH, Smoorenburg GF.
    Hear Res; 1998 Oct; 124(1-2):99-107. PubMed ID: 9822907
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Perilymphatic application of alpha-melanocyte stimulating hormone ameliorates hearing loss caused by systemic administration of cisplatin.
    Wolters FL, Klis SF, Hamers FP, de Groot JC, Smoorenburg GF.
    Hear Res; 2004 Mar; 189(1-2):31-40. PubMed ID: 14987750
    [Abstract] [Full Text] [Related]

  • 9. Protective effects of a neurotrophic ACTH(4-9) analog on cisplatin ototoxicity in relation to the cisplatin dose: an electrocochleographic study in albino guinea pigs.
    Stengs CH, Klis SF, Huizing EH, Smoorenburg GF.
    Hear Res; 1998 Oct; 124(1-2):108-17. PubMed ID: 9822908
    [Abstract] [Full Text] [Related]

  • 10. Acute changes in cochlear potentials due to cisplatin.
    Tsukasaki N, Whitworth CA, Rybak LP.
    Hear Res; 2000 Nov; 149(1-2):189-98. PubMed ID: 11033258
    [Abstract] [Full Text] [Related]

  • 11. Acceleration of cisplatin ototoxicity by perilymphatic application of 4-methylthiobenzoic acid.
    Cappaert NL, Klis SF, Wijbenga J, Smoorenburg GF.
    Hear Res; 2005 May; 203(1-2):80-7. PubMed ID: 15855032
    [Abstract] [Full Text] [Related]

  • 12. Systemic co-treatment with alpha-melanocyte stimulating hormone delays hearing loss caused by local cisplatin administration in guinea pigs.
    Wolters FL, Klis SF, de Groot JC, Hamers FP, Prieskorn DM, Miller JM, Smoorenburg GF.
    Hear Res; 2003 May; 179(1-2):53-61. PubMed ID: 12742238
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Cisplatin ototoxicity involves organ of Corti, stria vascularis and spiral ganglion: modulation by alphaMSH and ORG 2766.
    Hamers FP, Wijbenga J, Wolters FL, Klis SF, Sluyter S, Smoorenburg GF.
    Audiol Neurootol; 2003 May; 8(6):305-15. PubMed ID: 14566101
    [Abstract] [Full Text] [Related]

  • 15. [Effects of perilymphatic perfusion with cisplatin on the cochlear potential in guinea pigs].
    Wu DZ.
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 1990 Aug; 25(4):202-4, 254. PubMed ID: 2076322
    [Abstract] [Full Text] [Related]

  • 16. Pathophysiology of the ototoxicity of cis-diamminedichloroplatinum.
    Komune S, Asakuma S, Snow JB.
    Otolaryngol Head Neck Surg; 1981 Aug; 89(2):275-82. PubMed ID: 6787526
    [Abstract] [Full Text] [Related]

  • 17. Electrophysiological and morphological evaluation of the acute ototoxicity of sodium nitroprusside.
    Kong WJ, Ren T, Nuttall AL.
    Hear Res; 1996 Sep 15; 99(1-2):22-30. PubMed ID: 8970810
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.